Ethicon Medical Device Company Intelligence Report

Date: April 30, 2012
Pages: 36
Price:
US$ 340.00
Publisher: Espicom Business Intelligence
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: E104CF35B1AEN
Leaflet:

Download PDF Leaflet

Ethicon Medical Device Company Intelligence Report
Founded in 1949, Ethicon is best known as the world's leading suture company. Since then, the company has focused its expertise of understanding the complex ways in which biomaterials interact with the tissue of the human body to create a portfolio of products that advance healthcare across several areas including: wound closure; hernia surgery; biosurgery; women’s health and aesthetics. The latest addition to complement these businesses is products in the ear, nose and throat (ENT) sector.
  • Wound closure includes the world’s largest portfolio of synthetic sutures, PLUS Coated Antibacterial sutures and Dermabond Topical Skin Adhesive.
  • Hernia solutions includes a portfolio of mesh for use in hernia repair including Proceed Surgical Mesh, PhysioMesh Flexible Composite Mesh and the recently-approved SecureStrap 5mm Strap Fixation Device, which represented the company's first entry into the hernia mesh fixation market.
  • Women’s health includes what is claimed to be the largest portfolio of products on the market for conditions including incontinence, pelvic floor prolapse and for use in uterine surgery. These products are sold under the Gynecare brand.
  • Biosurgery comprises a portfolio of options for surgical haemostasis, which was expanded in 2008 with the acquisition of Omrix Biopharmaceuticals. Products include Evicel Fibrin Sealant (Human) and Omnex Surgical Sealant, the company's first synthetic internal-use sealant, while its Biopatch product offers infection-resistant wound dressings.
  • Aesthetics, capitalising on the 2009 acquisition of breast implant leader Mentor, which now reports as a business unit of Ethicon. Mentor also produces other plastic surgery products and expanded into the facial surgical aesthetics market with the launch of the PDS Flexible Plate, an absorbable implant that provides structural support and streamlines cartilage management during nasal reconstruction procedures.
  • ENT, an area of focus through the 2010 acquisition of Acclarent, whose Balloon Sinuplasty procedure provides an alternative to the current standard of care for patients who suffer from symptoms of chronic rhinosinusitis.
  • Ethicon has its headquarters in Somerville, New Jersey, US. It also has facilities in Georgia, Texas, and North Carolina in the US; Auneau, France; Aurangabad and Dharavi (Mumbai), India; Juarez, Mexico; Kirkton (Scotland) and Gargrave, UK; Neuchatel, Switzerland; Norderstedt, Germany; San Lorenzo, Puerto Rico; Sao Jose dos Campos, Brazil; Kiryat-Ono, Israel; and Shanghai, China.
In 2011, Ethicon generated sales of almost US$4.9 billion and employed approximately 8,500 people.

This company report provides
  • Overview
    • Key contact information
    • Introduction to the company and its current activities
    • Summary of its financial performance
    • Who are the company’s major competitors?
    • Key recent events in an “at a glance” format
  • Financial Review
    • Current year and annual financial data, including revenue breakdowns by product area and geographic region (if available)
    • Table providing in-depth five-year financial analysis
    • Employee data, including breakdown by company division and geographic location
  • Strategic Focus
    • Investigates the company’s aims and its areas of focus
  • Products
    • Core product areas, key brands, product approvals and launches Research and Development
    • How much has been invested in R&D?
    • Where is the research based?
    • What alliances and agreements does the company have and with whom?
  • Manufacturing and Distribution
    • Identifying the company’s manufacturing locations
    • Sales and marketing facilities
  • Agreements
    • With whom has the company reached agreements and what do they involve?
    • Key contracts awarded
  • Mergers, Acquisitions, Minority Investments and Divestments
  • Litigation
  • Key Corporate Events
OVERVIEW

FINANCIAL REVIEW

First Quarter 2012 Financial Results
2011 Financial Results

STRATEGIC FOCUS

PRODUCTS

Wound Closure
  Sutures
  Dermabond Skin Adhesive
  Prineo Skin Closure System
Mesh and Hernia Repair Solutions
  Inguinal Hernia Products
  Ventral Hernia Products
  Umbilical Hernia Products
Women’s Health
Biosurgicals
Aesthetic Medicine
  Breast Implants
  Expanders
  Dermis
  Body Contouring
  Facial Aesthetics
Infection Control
Ear, Nose and Throat

RESEARCH AND DEVELOPMENT

Studies and Trials
  Synthetic Mesh Can Improve Outcome Of Prolapse Surgery
  CDC Guidelines for Prevention of Intravascular Catheter-Associated Infections Designate
  Spectra Breast Implant Study

MANUFACTURING

US
Brazil
Mexico
Puerto Rico
France
Germany
UK
India

AGREEMENTS

  Angiotech Pharmaceuticals
  Conceptus Inc
  Cardio Access
  Musculoskeletal Transplant Foundation
  FzioMed
  Omrix Biopharmaceuticals
  American Medical Systems
Mentor
  Misonix
  Genzyme
  Tutogen Medical (RTI Biologics)
  Niadyne
  Wisconsin Alumni Research Foundation (WARF)

MERGERS AND ACQUISITIONS

  Angiotech's Quill Technology
  Acclarent
  Mentor
  Omrix Biopharmaceuticals
  Vascular Control Systems
  Closure Medical
  FemRx
  BEI Medical Systems’ GyneSys and HysteroSys Product Lines
  Gynecare
  Indigo Medical
Mentor
  Perouse Plastie
  Inform Solutions
  AMI’s Uterine Disorder Products
  A-Life
  Rights to ObTape
  Mills Biopharmaceuticals
  Portex’ Urology and Ostomy Business
  Byron Medical
  ProSurg Stress Incontinence Product
  Porgès
  DesChutes Medical Products’ Pessary Line
  South Bay Medical
  Sierra Laboratories
  Needles & Infusion Technologies’ Product Line
  Boston Pacific Medical Devices
  Teknar
  Mentor O&O
  Heyer-Schulte

DIVESTITURES

  Professional Wound Care Business
  CardioVations
  Clearglide Endoscopic Vessel Harvesting Products
  Sterion
Mentor
  Surgical Urology and Clinical and Consumer Healthcare Divisions
  UK Urisheath Business and US Manufacturing Assets
  North American Scientific
  Ophthalmics Phaco Cataract Removal Business
  Ophthalmology Division - Certain Assets
  Intraocular Lens Business

LITIGATION

Gynecare Mesh

KEY CORPORATE EVENTS

LIST OF TABLES

SUMMARY OPERATING RESULTS
Recent Key Events
Johnson & Johnson's General Surgery Franchise - First Quarter 2012 Sales
Johnson & Johnson's Specialty Surgery Franchise - First Quarter 2012 Sales
Ethicon - Annual Sales, 2007-2011
Ethicon – Hernia Repair Sales and Market Growth
Ethicon – Summary of Selected Product Approvals and Planned Submissions as of April 2012
Ethicon - Principal Manufacturing Facilities
Agreements Summary
Mergers and Acquisitions Summary
Mergers and Acquisitions Summary
Ethicon - Key Corporate Events

LIST OF CHARTS

Johnson & Johnson - Medical Devices & Diagnostics Segment Sales by Franchise, 2011
Ethicon - Annual Sales, 2007-2011
Ethicon - Annual Sales by Geographic Area, 2007-2011
Skip to top


Ask Your Question

Ethicon Medical Device Company Intelligence Report
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: